2020

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international Stanford Medicine-led team publishes landmark studies detailing new findings and potential therapies.

Artificial intelligence and digital technology experts convened to discuss the benefits, challenges and potential of a digitally driven future in biomedical research and health care.

Blood tests for colorectal cancer are an option for patients who would otherwise not be screened, but they are not as effective as colonoscopies or stool tests, a Stanford Medicine-led study found.

The goal of the Clinical and Translational Science Award is to convert new treatments into care more rapidly.

Stanford researchers hope new technique will flip lymphoma protein’s normal action — from preventing cell death to triggering it.

Konstantina Stankovic and David Studdert join the distinguished society of scientists.

Some patients hospitalized for an emergency illness or injury will develop mental health problems months after the experience. A new screening tool can anticipate who’s most at risk.

The Center for Dissemination and Implementation will receive $37 million to improve access to effective mental health services, including underserved populations.

Stanford Medicine researchers, after creating an AI-based algorithm to find complex structural variants in the human genome, learned those variants likely contribute to psychiatric disease.

A Stanford Medicine-led study found that residual liver cancer cells interact with neighboring macrophages to prompt the disease to reappear.